Ole C. Lingjaerde

Oslo, 0373, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications

Correction: Lien et al. Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer. Cancers 2021, 13, 6118.

Correction: Lien et al. Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer. Cancers 2021, 13, 6118.

Journal: Cancers
Published: March 25, 2026

Elevated KRAS protein level is associated with better survival in pancreatic cancer.

Elevated KRAS protein level is associated with better survival in pancreatic cancer.

Journal: BMC cancer
Published: April 27, 2025

High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy.

High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy.

Journal: Breast cancer research : BCR
Published: March 23, 2025

The harmonized activities of HER2-HER3 heterodimer and deacetylated FOXA1 evade hormone response by regulating FOXA1 chromatin binding.

The harmonized activities of HER2-HER3 heterodimer and deacetylated FOXA1 evade hormone response by regulating FOXA1 chromatin binding.

Journal: Nucleic acids research
Published: January 03, 2025

StarSignDNA: mutation-to-signature attribution for accurate representation of mutational processes in low-mutation contexts.

StarSignDNA: mutation-to-signature attribution for accurate representation of mutational processes in low-mutation contexts.

Journal: NAR genomics and bioinformatics
Published: January 02, 2025

High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis.

High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis.

Journal: Communications medicine
Published: October 20, 2024

Single-cell analysis reveals tumour size as a key driver of immune cell profile alterations in primary breast tumours and corresponding lymph nodes.

Single-cell analysis reveals tumour size as a key driver of immune cell profile alterations in primary breast tumours and corresponding lymph nodes.

Journal: BJC reports
Published: July 08, 2024

Gut microbiota diversity is prognostic and associated with benefit from chemo-immunotherapy in metastatic triple-negative breast cancer.

Gut microbiota diversity is prognostic and associated with benefit from chemo-immunotherapy in metastatic triple-negative breast cancer.

Journal: Molecular oncology
Published: May 05, 2024

Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma.

Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma.

Journal: Blood cancer journal
Published: January 19, 2024

Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial.

Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial.

Journal: Journal for immunotherapy of cancer
Published: December 27, 2023

Preoperative profiles of plasma amino acids and derivatives distinguish periampullary cancer and benign disease.

Preoperative profiles of plasma amino acids and derivatives distinguish periampullary cancer and benign disease.

Journal: BMC cancer
Published: December 04, 2023

Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy.

Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy.

Journal: Leukemia & lymphoma
Published: September 08, 2023
Showing 1-12 of 87

Last Updated: 09/26/2026